Literature DB >> 25413922

Evaluation of somatic embryos of alfalfa for recombinant protein expression.

Guohua Fu1, Vojislava Grbic, Shengwu Ma, Lining Tian.   

Abstract

KEY MESSAGE: Somatic embryos of alfalfa can accumulate higher levels of recombinant proteins comparing to vegetative organs. Somatic embryos may be explored as a new system for new protein production for plants. Plants have been explored via genetic engineering as an inexpensive system for recombinant protein production. However, protein expression levels in vegetative tissues have been low, which limits the commercial utilization of plant expression systems. Somatic embryos resemble zygotic embryos in many aspects and may accumulate higher levels of proteins as true seed. In this study, somatic embryo of alfalfa (Medicago sativa L.) was investigated for the expression of recombinant proteins. Three heterologous genes, including the standard scientific reporter uid that codes for β-glucuronidase and two genes of interest: ctb coding for cholera toxin B subunit (CTB), and hIL-13 coding for human interleukin 13, were independently introduced into alfalfa via Agrobacterium-mediated transformation. Somatic embryos were subsequently induced from transgenic plants carrying these genes. Somatic embryos accumulated approximately twofold more recombinant proteins than vegetative organs including roots, stems, and leaves. The recombinant proteins of CTB and hIL-13 accumulated up to 0.15 and 0.18 % of total soluble protein in alfalfa somatic embryos, respectively. The recombinant proteins expressed in somatic embryos also exhibited biological activities. As somatic embryos can be induced in many plant species and their production can be scaled up via different avenues, somatic embryos may be developed as an efficient expression system for recombinant protein production.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25413922     DOI: 10.1007/s00299-014-1700-x

Source DB:  PubMed          Journal:  Plant Cell Rep        ISSN: 0721-7714            Impact factor:   4.570


  41 in total

Review 1.  The production of recombinant pharmaceutical proteins in plants.

Authors:  Julian K-C Ma; Pascal M W Drake; Paul Christou
Journal:  Nat Rev Genet       Date:  2003-10       Impact factor: 53.242

2.  Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants.

Authors:  Dora Li; Jennifer O'Leary; Yan Huang; Norman P A Huner; Anthony M Jevnikar; Shengwu Ma
Journal:  Plant Cell Rep       Date:  2005-12-02       Impact factor: 4.570

3.  Synthesis and self-assembly of a functional monoclonal antibody in transgenic Nicotiana tabacum.

Authors:  K Düring; S Hippe; F Kreuzaler; J Schell
Journal:  Plant Mol Biol       Date:  1990-08       Impact factor: 4.076

4.  A critical role for IL-13 in resistance to intestinal nematode infection.

Authors:  A J Bancroft; A N McKenzie; R K Grencis
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

5.  Plant recombinant erythropoietin attenuates inflammatory kidney cell injury.

Authors:  Andrew J Conley; Kanishka Mohib; Anthony M Jevnikar; Jim E Brandle
Journal:  Plant Biotechnol J       Date:  2008-11-26       Impact factor: 9.803

Review 6.  Green factories for biopharmaceuticals.

Authors:  S Melnik; E Stoger
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 7.  Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants.

Authors:  H Daniell; S J Streatfield; K Wycoff
Journal:  Trends Plant Sci       Date:  2001-05       Impact factor: 18.313

8.  Interaction of Polycomb-group proteins controlling flowering in Arabidopsis.

Authors:  Yindee Chanvivattana; Anthony Bishopp; Daniel Schubert; Christine Stock; Yong-Hwan Moon; Z Renee Sung; Justin Goodrich
Journal:  Development       Date:  2004-09-29       Impact factor: 6.868

9.  Direct control of hepatic glucose production by interleukin-13 in mice.

Authors:  Kristopher J Stanya; David Jacobi; Sihao Liu; Prerna Bhargava; Lingling Dai; Matthew R Gangl; Karen Inouye; Jillian L Barlow; Yewei Ji; Joseph P Mizgerd; Ling Qi; Hang Shi; Andrew N J McKenzie; Chih-Hao Lee
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

10.  Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro.

Authors:  L J Montaner; A G Doyle; M Collin; G Herbein; P Illei; W James; A Minty; D Caput; P Ferrara; S Gordon
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  1 in total

1.  Multiple Authorship in Scientific Manuscripts: Ethical Challenges, Ghost and Guest/Gift Authorship, and the Cultural/Disciplinary Perspective.

Authors:  Jaime A Teixeira da Silva; Judit Dobránszki
Journal:  Sci Eng Ethics       Date:  2015-10-27       Impact factor: 3.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.